Matin Behzad Karami, Azami Saeed Reza, Mahmoudi Saeid, Rezaei Satar, Shaahmadi Faramarz, Karyani Ali Kazemi
Ph.D. of Health Services Management, Associate Professor, Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Ph.D. Student of Health Services Management, Vice Chancellor of Management and Resource Development, Student Welfare Found, Ministry of Health, Tehran, Iran.
Electron Physician. 2015 Nov 20;7(7):1470-5. doi: 10.19082/1470. eCollection 2015 Nov.
In recent decades, the development of medical and pharmaceutical science has led to a heavy financial burden on the government, insurance companies, and the general population. Due to the increasing the cost of pharmaceutical products in the Kermanshah Province, policy makers have tried to identify the factors that resulted in the increases. The aim of this study was to determine the main factors that affect the expenditures for pharmaceutical products by urban households in Kermanshah Province, Iran.
This analytical-descriptive study was conducted using time series method. The study population was urban households of Kermanshah Province from 1991 to 2013. The explanatory variables of the log-log model were drug price index (LnDPI), the average income of urban households (LnINC), the number of physicians per 1,000 people (LnPH), and the number of hospital beds per 1,000 people (LnBE).The required data were acquired from the Statistical Center of the Ministry of Health and Medical Education. The unit root was evaluated by the Dickey-Fuller test. Stata v.11 software was used for the statistical analysis.
Coefficients of LnDPI and LnPH were 0.97 and 0.77, respectively, and they were statistically significant (p < 0.05). Also, the coefficients of D. LnINC (first difference of LnINC) and LnBE were 0.34 and 1.8, respectively, and both of them were statistically insignificant (p > 0.05).
The results showed that drugs are non-elastic and essential for households. It should be noted that the health policy makers in Iran should conduct appropriate planning to ensure both the physical and financial accessibility to drugs by urban households. The development of basic and supplementary health insurance coverage, especially for poor populations and urban areas where there are patients with chronic diseases, can be a suitable solution to reduce barriers to acquiring the required drugs.
近几十年来,医学和制药科学的发展给政府、保险公司和普通民众带来了沉重的经济负担。由于克尔曼沙阿省药品价格不断上涨,政策制定者试图找出导致价格上涨的因素。本研究的目的是确定影响伊朗克尔曼沙阿省城市家庭药品支出的主要因素。
本分析描述性研究采用时间序列法。研究对象为1991年至2013年克尔曼沙阿省的城市家庭。对数-对数模型的解释变量为药品价格指数(LnDPI)、城市家庭平均收入(LnINC)、每千人口医生数量(LnPH)和每千人口医院床位数(LnBE)。所需数据来自卫生和医学教育部统计中心。通过迪基-富勒检验评估单位根。使用Stata v.11软件进行统计分析。
LnDPI和LnPH的系数分别为0.97和0.77,且具有统计学意义(p<0.05)。此外,D. LnINC(LnINC的一阶差分)和LnBE的系数分别为0.34和1.8,两者均无统计学意义(p>0.05)。
结果表明,药品对家庭来说缺乏弹性且必不可少。应当指出,伊朗的卫生政策制定者应进行适当规划,以确保城市家庭在药品的实际获取和经济承受能力方面都能得到保障。发展基本和补充医疗保险覆盖范围,特别是针对贫困人口以及有慢性病患者的城市地区,可能是减少获取所需药品障碍的合适解决方案。